SCHEMBL2580143

SCHEMBL2580143

ClNc1ccc(Br)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15147441 0.83 ALDH1A1 (0.33)
SCHEMBL1954970 0.77 IDO1 (0.45)
SCHEMBL13148721 0.73 CYP2A6 (0.57)
SCHEMBL409605 0.73 CYP2A6 (0.57)
SCHEMBL17223076 0.73 CYP2A6 (0.57)
SCHEMBL16526973 0.73 CYP2A6 (0.57)
SCHEMBL8990842 0.73 HTT (0.38)
SCHEMBL1187788 0.71
SCHEMBL1103762 0.71
SCHEMBL18508 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271323-A WRN inhibitors 苏州浦合医药科技有限公司 2024-07-02 CN disclosed
CN-109988105-A Heterocyclic nitrogen compound and preparation method thereof as kinases inhibitor 天津滨江药物研发有限公司 2019-07-09 CN disclosed
CN-108658937-A A kind of bicyclic alkaloid compound and its preparation method and application 中国海洋大学 2018-10-16 CN disclosed
CN-108383875-A A kind of the 3- phosphonomethyls indoline and preparation method of silver catalysis 昆明学院 2018-08-10 CN disclosed
CN-105384754-B Heterocycle compound as kinases inhibitor and its preparation method and application 上海科州药物研发有限公司 2018-04-20 CN disclosed
CN-106565625-B A kind of antiplatelet reduces the preparation method of disease new drug Lusutrombopag intermediates 杭州励德生物科技有限公司 2018-01-30 CN disclosed
WO-2017214505-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2017-12-14 WO disclosed
CN-106565625-A Preparation method for intermediates of new medicine Lusutrombopag resisting to thrombopenia 杭州励德生物科技有限公司 2017-04-19 CN disclosed
CN-104230826-B 2 fluoro quinazoline cyclics and preparation method thereof and pharmaceutical usage 复旦大学 2017-03-29 CN disclosed
CN-105384754-A Heterocyclic compounds serving as protein kinase inhibitors and preparation method for heterocyclic compounds and application of heterocyclic compounds KECHOW PHARMA INC 2016-03-09 CN disclosed
CN-103097353-A Novel immunomodulator and anti-inflammatory compounds INCOZEN THERAPEUTICS PVT LTD 2013-05-08 CN disclosed
US-8436027-B2 Azole compounds used as tuberculostatic and leishmanicide agents Fundacão Oswaldo Cruz—FIOCRUZ (BR) 2013-05-07 US disclosed
EP-2566847-A1 NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS Icozen Therapeutics Pvt. Ltd. (IN) 2013-03-13 EP disclosed
WO-2011138665-A1 NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS INCOZEN THERAPEUTICS PVT. LTD. (IN) 2011-11-10 WO disclosed
US-20110269803-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS FUNDACAO OSWALDO CRUZ - FIOCRUZ (BR) 2011-11-03 US disclosed
CN-102137837-A PAI-1 inhibitor INST MED MOLECULAR DESIGN INC 2011-07-27 CN disclosed
US-20090054501-A1 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS BOECHAT NUBIA 2009-02-26 US disclosed
EP-1976832-A2 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS Fundacao Oswaldo Cruz - Fiocruz (BR) 2008-10-08 EP disclosed
WO-2007019660-A2 AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS Fundação Oswaldo Cruz - FIOCRUZ (BR) 2007-02-22 WO disclosed
US-4353734-A PRE- AND POSTEMERGENCE CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) 1982-10-12 US disclosed